Overall rank by patents
#7,407
of 50,000 tracked assignees
USPTO PatentsView assignee record - 44 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
According to USPTO PatentsView, Fertin ranks #7,407 of 50,000 tracked US assignees by granted-patent volume, with 44 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R7407 · Foreign Corporation #7,407 · 44 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Fastcap Systems Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
GED Integrated Solut… · near
44 score
Fertin Pharma A/s · this assignee
44 score
HBI Branded Apparel… · near
44 score
Series International · near
44 score
Hampton Products Int… · near
44 score
3D Lighting Innovati… · lowest
7 score
What this shows Fertin Pharma A/s stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-FRNCORP, VEL-SURGE, BOOK-FULL. Volume places it #7,407 of 50,000; Innovation Score 43.9/100 sits in the top 27% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Fastcap Systems Corporation (±0 grants).
Fertin Pharma A/s has been granted 44 US utility patents between 2015 and 2025, placing Fertin Pharma A/s at #7,407 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.4 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Fertin Pharma A/s is one of the more focused assignees in the PatentsView dataset. By volume, Fertin sits between Fastcap Systems Corporation (44 patents, rank #7,404) and GOAL ZERO Llc (44 patents, rank #7,412) - the closest US assignees by grant volume. The composite Innovation Score of 43.9/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 29 grants, compared with 13 in the 2015–2019 window, a +123% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Fertin Pharma A/s's 20.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 12 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
FASTCAP SYSTEMS CORPORATION
44 patents
FUJIFILM NORTH AMERICA CORPORATION
44 patents
Faurecia Emissions Control Technologies, Germany GmbH
44 patents
Femasys Inc.
44 patents
Fette Compacting GmbH
44 patents
GD MIDEA ENVIRONMENT APPLIANCES MFG CO., LTD.
44 patents
GE Healthcare BioProcess R&D AB
44 patents
GOAL ZERO LLC
44 patents
Fertin Pharma A/S
44 patents
What this shows Fertin holds 44 patents at rank #7,408, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #7,408 in granted patent volume.
Other assignees with the most granted patents in Fertin's primary technology class.
Two PlainPatent-derived peer sets for Fertin, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (44 here).
Fertin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 9.1% |
| 2016 | 3 | 6.8% |
| 2017 | 2 | 4.5% |
| 2019 | 4 | 9.1% |
| 2020 | 3 | 6.8% |
| 2021 | 10 | 22.7% |
| 2022 | 4 | 9.1% |
| 2023 | 5 | 11.4% |
| 2024 | 7 | 15.9% |
| 2025partial year | 2 | 4.5% |
Top 12 of 12 technology areas
Overall rank by patents
#7,407
of 50,000 tracked assignees
43.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.